Current best evidence for clinical care
COVID-19 Evidence Alerts alerts users to current best evidence for clinical care of people with threatened, suspected or confirmed COVID-19 infection. It is updated every weekday as evidence reports are published in all journals included in MEDLINE. Reports are critically appraised for scientific merit, and those with acceptable scientific merit are appraised for relevance and importance by frontline clinicians.
Study reports that provide lower-quality scientific evidence that appears to be relevant to the diagnosis, prevention and treatment, harm from treatments, prognosis, clinical prediction, guidelines, are also posted, with at least one reason for their lower quality (eg, nonrandomized trial, loss of >20% of patients to follow-up).
As of the end of March 2020, the amount of higher-quality evidence to support COVID-specific clinical action is extremely limited. COVID-19 Evidence Alerts will thus find the best available evidence, including studies "below the line" of high-quality and clinical relevance, as defined on our website. Evidence "above-the-line" is clearly distinguished from evidence that does not meet this standard.
Subscribers to ACCESSSS, EvidenceAlerts, or ACP JournalWise can opt in to receive COVID-19 Evidence Alerts most easily through the link provided on the landing page of those services, without need to register. Non-subscribers can register to COVID-19 Evidence Alerts here.
Registration is free.
Hello! We would like to hear about your experiences with COVID-19 EA. Are you interested in sharing feedback through a quick 10-minute survey?
Thank you for your interest! You may navigate to the survey at any time by clicking the designated button at the top of the page.
Thank you. Should you decide to participate at a later time, you can access the survey by clicking the designated button at the top of the page.